About Jiuzhitang
Jiuzhitang is a company based in Changsha (China) founded in 1994.. The company has 3,690 employees as of December 31, 2024. Jiuzhitang operates in a competitive market with competitors including AmerisourceBergen, Dizal Pharma, Quanyuantang Pharmacy, Guiyang Xintian Pharmaceutical and Sinopharm Online, among others.
- Headquarter Changsha, China
- Employees 3690 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Jiuzhitang Co., Ltd. Class A
-
Annual Revenue
$319.2 M (USD)-20.08as on Dec 31, 2024
-
Net Profit
$29.62 M (USD)-27.31as on Dec 31, 2024
-
EBITDA
$40.34 M (USD)-28.01as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
3690
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Jiuzhitang
Jiuzhitang is a publicly listed company on the SZSE with ticker symbol 000989 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Jiuzhitang
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Jiuzhitang
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Jiuzhitang
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jiuzhitang Comparisons
Competitors of Jiuzhitang
Jiuzhitang operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Dizal Pharma, Quanyuantang Pharmacy, Guiyang Xintian Pharmaceutical and Sinopharm Online, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical research and development are focused on oncology therapeutics.
|
|
| domain | founded_year | HQ Location |
Medical and pharmaceutical products are retailed offline and online.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical company in China
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products are sold via an e-commerce platform in China.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jiuzhitang
Frequently Asked Questions about Jiuzhitang
When was Jiuzhitang founded?
Jiuzhitang was founded in 1994.
Where is Jiuzhitang located?
Jiuzhitang is headquartered in Changsha, China. It is registered at Changsha, Hunan, China.
How many employees does Jiuzhitang have?
As of Dec 31, 2024, the latest employee count at Jiuzhitang is 3,690.
What is the annual revenue of Jiuzhitang?
Annual revenue of Jiuzhitang is $319.2M as on Dec 31, 2024.
What does Jiuzhitang do?
Jiuzhitang, established in 1994, excels in providing healthcare solutions, pharmaceutical distributors, and diversified. Distributor of pharmaceutical products. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of Jiuzhitang?
Jiuzhitang's top competitors include AmerisourceBergen, Dizal Pharma and Guiyang Xintian Pharmaceutical.
Is Jiuzhitang publicly traded?
Yes, Jiuzhitang is publicly traded on SZSE under the ticker symbol 000989.
What is Jiuzhitang's ticker symbol?
The ticker symbol of Jiuzhitang is 000989 on SZSE.